ArticleiScience2026

IGFL2 suppresses gastric cancer cell sensitivity to docetaxel by activating the Toll-like receptor signaling pathway.

Wei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.